The chart below shows the treatment plan for the participants.
Roxadustat rHuEPO
13 participants 12 participants
Through a needle into a vein
Tablets by mouth or into the skin
2 or 3 times per week depending on the dose of
3 times per week rHuEPO they had received before joining the trial
For 2 weeks total
For 2 weeks total
-